Australian Children with Peanut Allergies to Receive Groundbreaking Life-Saving Treatment

Strategic Insights -

A nationwide program in Australia will provide daily doses of peanut powder to infants with potentially deadly peanut allergies, aiming to build up their tolerance and potentially lead to remission. The program, offered in 10 pediatric hospitals, is the first national peanut allergy treatment program outside of a clinical trial setting. Eligible babies will receive increasing doses of peanut powder over two years, under the supervision of doctors, in a bid to reduce their sensitivity to peanuts.

Key Takeaways:

  • The program aims to change the trajectory of allergic disease in Australia by reducing the risk of life-threatening peanut reactions.
  • Peanut allergies affect three percent of Australian children by the time they are 12 months old, with only 20 percent outgrowing the allergy by the time they are teenagers.
  • The program will involve daily doses of peanut powder for two years, with increasing doses to build up tolerance, under the supervision of doctors at 10 pediatric hospitals.
  • At the end of the two years, a food allergy test will determine if the treatment has led to remission.
  • The program is free and available at public hospitals, which is seen as a game-changer for families desperate to protect their children from allergic reactions and anaphylaxis.
  • The program will be rolled out more broadly, including in regional and remote areas, if successful.
  • Deaths from peanut allergies are rare in Australia, but almost 20 percent of the population has an allergic disease, which is estimated to grow by 70 percent by 2050, impacting 7.7 million Australians.

Statistics:

  • 3% of Australian children have peanut allergies by the time they are 12 months old.
  • 20% of children with peanut allergies will outgrow the allergy by the time they are teenagers.
  • 7.7 million Australians are estimated to be impacted by allergic diseases by 2050.
  • The number of people with allergic diseases is estimated to grow by 70% by 2050.
  • Almost 20% of the Australian population has an allergic disease.

Sources:

  • https://www.japantoday.com
  • Yerepouni Daily News (2022)